Search results for "FDA update"


 
Results 81 - 88 of about 88 for "FDA update".
Sort by: Relevance | Newest | Oldest

First continuous glucose monitoring system approved to be used with other devices

The system is the first approved to be used with other diabetes devices, such as automated insulin-dosing systems, insulin pumps, or blood glucose meters, according to the FDA.
https://diabetes.acponline.org/archives/2018/04/13/6.htm
13 Apr 2018

FDA approves new treatment for diabetic foot ulcers

The approval is an expanded indication for the device, which covers the ulcer and allows skin and tissue to regenerate and heal the wound.
https://diabetes.acponline.org/archives/2016/02/12/6.htm
12 Feb 2016

Test strips recalled

Twenty lots of Abbott's FreeStyle and FreeStyle Lite blood glucose test strips were recalled.
https://diabetes.acponline.org/archives/2014/02/14/9.htm
14 Feb 2014

New warnings for fluoroquinolones about risk of hypoglycemic coma

The labeling changes for fluoroquinolones will also make the mental health side effects more prominent and more consistent across the drug class.
https://diabetes.acponline.org/archives/2018/08/10/9.htm
10 Aug 2018

FDA authorizes marketing of first interoperable, automated insulin dosing controller

The device automatically adjusts insulin delivery to a person with diabetes by connecting to an alternate controller-enabled insulin pump and integrated continuous glucose monitor.
https://diabetes.acponline.org/archives/2020/01/10/6.htm
10 Jan 2020

New warnings on medications containing saxagliptin, alogliptin

New warnings will be placed on saxagliptin and alogliptin about the potential risk of heart failure, particularly in patients with heart or kidney disease, the FDA announced on April 5.
https://diabetes.acponline.org/archives/2016/04/08/5.htm
8 Apr 2016

Semaglutide injection approved for chronic weight management

First approved to treat type 2 diabetes in 2017, the drug has a new indication for chronic weight management in adults with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related condition, such as type 2 diabetes, and those with a BMI of 30 kg/m2 or greater.
https://diabetes.acponline.org/archives/2021/06/11/11.htm
11 Jun 2021

New contraindication for aliskiren-containing medications

Aliskiren-containing medications are contraindicated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with diabetes.
https://diabetes.acponline.org/archives/2012/07/13/10.htm
13 Jul 2012

Result Page: Prev   4   5   6   7   8   9   Next